With our experimental setting we have shown for the first time that the DAMP HMGB1 is only released from HPV-positive HNSCC tumor cells after fractionated irradiation and that this can be significantly enhanced with taxane-based chemotherapy. This evidence concerns the gene HMGB1 and neoplasm.